3-[1-Methyl-5-(morpholine-4-sulfonyl)-1H-1,3-benzodiazol-2-yl]propanoic acid

Catalog No.: 
ACMZGJ834
CAS No.: 
731820-90-9
Molecular Formula: 
C15H19N3O5S
Molecular Weight: 
353.40
3-[1-Methyl-5-(morpholine-4-sulfonyl)-1H-1,3-benzodiazol-2-yl]propanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$100.00InquiryInquiry
5g95%$946.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-[1-Methyl-5-(morpholine-4-sulfonyl)-1H-1,3-benzodiazol-2-yl]propanoic acid
IUPAC Name3-(1-methyl-5-(morpholinosulfonyl)-1H-benzo[d]imidazol-2-yl)propanoic acid
MDL No.MFCD04628447
Molecular FormulaC15H19N3O5S
Molecular Weight353.40
SMILESO=C(O)CCC1=NC2=CC(S(=O)(N3CCOCC3)=O)=CC=C2N1C
InChI KeyQVDXUOYLRVRYJZ-UHFFFAOYSA-N
Synonym1H-Benzimidazole-2-propanoic acid, 1-methyl-5-(4-morpholinylsulfonyl)-;3-[1-methyl-5-(morpholine-4-sulfonyl)-1h-1,3-benzodiazol-2-yl]propanoic acid
CAS No.731820-90-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACMZGJ834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMZGJ834 route product structure diagram
    ACMZGJ834731820-90-9
Inquiry

2. ACMZGJ834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMZGJ834 route product structure diagram
    ACMZGJ834731820-90-9
Inquiry

3. ACMZGJ834 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMZGJ834 route product structure diagram
    ACMZGJ834731820-90-9
Inquiry

Comments (0)